The natural history of monoamniotic twin pregnancies: a case series and systematic review of the literature

2015 ◽  
Vol 35 (3) ◽  
pp. 274-280 ◽  
Author(s):  
Federico Prefumo ◽  
Anna Fichera ◽  
Giorgio Pagani ◽  
Daria Marella ◽  
Adriana Valcamonico ◽  
...  
Keyword(s):  
Systematic Review ◽  
Natural History ◽  
Case Series ◽  
Review Of The Literature ◽  
History Of ◽  
Twin Pregnancies

Management of monoamniotic twin pregnancies: a case series and systematic review of the literature

2001 ◽  
Vol 108 (9) ◽  
pp. 931-936 ◽  
Author(s):  
Victoria M Allen ◽  
Rory Windrim ◽  
Jon Barrett ◽  
Arne Ohlsson
Keyword(s):  
Systematic Review ◽  
Case Series ◽  
Review Of The Literature ◽  
Twin Pregnancies

Management of monoamniotic twin pregnancies: a case series and systematic review of the literature

2001 ◽  
Vol 108 (9) ◽  
pp. 931-936 ◽  
Author(s):  
Victoria M. Allen ◽  
Rory Windrim ◽  
Jon Barrett ◽  
Arne Ohlsson
Keyword(s):  
Systematic Review ◽  
Case Series ◽  
Review Of The Literature ◽  
Twin Pregnancies

Small bowel intussusception in pregnant women with a history of a Roux-en-Y gastric bypass: a case series and a systematic review of the literature

2020 ◽  
Vol 16 (10) ◽  
pp. 1603-1613 ◽  
Author(s):  
Daniëlle S. Bonouvrie ◽  
Loes Janssen ◽  
Hendrik J. Niemarkt ◽  
Judith O.E.H. van Laar ◽  
Wouter K.G. Leclercq ◽  
...  
Keyword(s):  
Systematic Review ◽  
Gastric Bypass ◽  
Small Bowel ◽  
Pregnant Women ◽  
Case Series ◽  
Review Of The Literature ◽  
Small Bowel Intussusception ◽  
History Of

Natural history of small duct primary sclerosing cholangitis: a case series with review of the literature

2011 ◽  
Vol 5 (3) ◽  
pp. 808-813 ◽  
Author(s):  
A. K. Singal ◽  
C. M. Stanca ◽  
V. Clark ◽  
L. Dixon ◽  
C. Levy ◽  
...  
Keyword(s):  
Natural History ◽  
Primary Sclerosing Cholangitis ◽  
Sclerosing Cholangitis ◽  
Case Series ◽  
Review Of The Literature ◽  
Small Duct ◽  
History Of

scholarly journals The Natural History of Severe Acute Respiratory Syndrome Coronavirus 2–Related Multisystem Inflammatory Syndrome in Children: A Systematic Review

2020 ◽  
Author(s):  
Stephen C Aronoff ◽  
Ashleigh Hall ◽  
Michael T Del Vecchio
Keyword(s):  
Systematic Review ◽  
Natural History ◽  
Severe Acute Respiratory Syndrome ◽  
Myocardial Dysfunction ◽  
Case Reports ◽  
Clinical Manifestations ◽  
Gastrointestinal Symptoms ◽  
Case Series ◽  
History Of ◽  
Inflammatory Syndrome

Abstract Background The clinical manifestations and natural history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–related multisystem inflammatory syndrome in children (MIS-C) are poorly defined. Using a systematic review of individual cases and case series and collating elements of the clinical course, the objective of this study was to provide a detailed clinical description and natural history of MIS-C. Methods Case reports and series of MIS-C were recovered from repeated MEDLINE searches, a single EMBASE search, and table of contents reviews of major general medicine and pediatric journals performed between June 3 and July 23, 2020. Fever, evidence of inflammation, and evidence of organ dysfunction were required for inclusion. Results MEDLINE and EMBASE searches produced 129 articles, and 10 articles were identified from journal contents or article bibliographies; 16 reports describing 505 children with MIS-C comprise this review. Thirty-two children (14.7%) had negative results for SARS-CoV-2 by nucleic acid and/or antibody testing. The weighted median age was 9 years (6 months to 20 years). Clinical findings included fever (100%), gastrointestinal symptoms (88.0%), rash (59.2%), conjunctivitis (50.0%), cheilitis/ “strawberry tongue” (55.7%), or extremity edema/erythema (47.5%). Median serum C-reactive protein, ferritin, fibrinogen, and D-dimer concentrations were above the normal range. Intravenous gammaglobulin (78.1%) and methylprednisolone/prednisone (57.6%) were the most common therapeutic interventions; immunomodulation was used in 24.3% of cases. Myocardial dysfunction requiring ionotropic support (57.4%) plus extracorporeal membrane oxygenation (5.3%), respiratory distress requiring mechanical ventilation (26.1%), and acute kidney injury (11.9%) were the major complications; anticoagulation was used commonly (54.4%), but thrombotic events occurred rarely (3.5%). Seven (1.4%) children died. Conclusions MIS-C following SARS-CoV-2 infection frequently presents with gastrointestinal complaints and/or rash; conjunctivitis, cheilitis, and/or extremity changes also occur frequently. Serious complications occur frequently and respond to aggressive supportive therapy.

Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess; a systematic review and meta-analysis

2018 ◽  
Author(s):  
Yasir Elhassan ◽  
Fares Alahdab ◽  
Alessandro Prete ◽  
Danae Delivanis ◽  
Aakanksha Khanna ◽  
...  
Keyword(s):  
Systematic Review ◽  
Natural History ◽  
Meta Analysis ◽  
Adrenal Incidentalomas ◽  
History Of

Dental Implant Placement in Patients with a History of Medications Related to Osteonecrosis of the Jaws: A Systematic Review

2020 ◽  
Author(s):  
Judd Sher ◽  
Kate Kirkham-Ali ◽  
Denny Luo ◽  
Catherine Miller ◽  
Dileep Sharma
Keyword(s):  
Systematic Review ◽  
At Risk ◽  
Drug Therapy ◽  
Dental Implant ◽  
Case Series ◽  
Cochrane Central Register ◽  
Bisphosphonate Treatment ◽  
Implant Placement ◽  
Increased Risk ◽  
History Of

The present systematic review evaluates the safety of placing dental implants in patients with a history of antiresorptive or antiangiogenic drug therapy. The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines were followed. PubMed, Cochrane Central Register of Controlled Trials, Scopus, Web of Science, and OpenGrey databases were used to search for clinical studies (English only) to July 16, 2019. Study quality was assessed regarding randomization, allocation sequence concealment, blinding, incomplete outcome data, selective outcome reporting, and other biases using a modified Newcastle-Ottawa scale and the Joanna Briggs Institute critical appraisal checklist for case series. A broad search strategy resulted in the identification of 7542 studies. There were 28 studies reporting on bisphosphonates (5 cohort, 6 case control, and 17 case series) and one study reporting on denosumab (case series) that met the inclusion criteria and were included in the qualitative synthesis. The quality assessment revealed an overall moderate quality of evidence among the studies. Results demonstrated that patients with a history of bisphosphonate treatment for osteoporosis are not at increased risk of implant failure in terms of osseointegration. However, all patients with a history of bisphosphonate treatment, whether taken orally for osteoporosis or intravenously for malignancy, appear to be at risk of ‘implant surgery-triggered’ MRONJ. In contrast, the risk of MRONJ in patients treated with denosumab for osteoporosis was found to be negligible. In conclusion, general and specialist dentists should exercise caution when planning dental implant therapy in patients with a history of bisphosphonate and denosumab drug therapy. Importantly, all patients with a history of bisphosphonates are at risk of MRONJ, necessitating this to be included in the informed consent obtained prior to implant placement. The James Cook University College of Medicine and Dentistry Honours program and the Australian Dental Research Foundation Colin Cormie Grant were the primary sources of funding for this systematic review.

Sign in / Sign up

Export Citation Format

Share Document